Literature DB >> 7332614

What controls smooth muscle phenotype?

J H Chamley-Campbell, G R Campbell.   

Abstract

Enzyme-dispersed smooth muscle cells from the adult pig aortic media in the first few days of primary culture are in the contractile phenotype and do not divide when challenged with 5% WBS. After 6--8 days the isolated cells spontaneously undergo a change in phenotype where contraction cannot be stimulated and the cells respond to mitogens in WBS by logarithmic growth. The change in phenotype is reversible if the cells are seeded sufficiently densely (5 x 10(4) to 1 x 10(5)/ml) that a confluent monolayer results after less than 1 week of proliferation, but is irreversible if the cells are seeded sparsely (1 x 10(3) to 5 x 10(3)/ml) and take more than 2 weeks of proliferation to reach confluence. When the cells are seeded so densely (10(6)/ml) that a confluent monolayer is present from day 1, the cells do not undergo a change in phenotype but remain indefinitely in the contractile state. The spontaneous modulation of phenotype of isolated smooth muscle cells can be inhibited by a confluent monolayer of contractile smooth muscle or endothelial cells in co-culture with the sparsely seeded smooth muscle such that the two cell layers are not in contact but bathed by the same nutrient medium. Smooth muscle modulation can also be inhibited by a factor extracted from pig and rabbit aortic tissue, and its effects mimicked by commercially available sodium heparin at 50 units/ml.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7332614     DOI: 10.1016/0021-9150(81)90145-3

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  45 in total

1.  Cell volume and rate of proliferation, but not protein expression pattern, distinguish pup/intimal smooth muscle cells from subcultured adult smooth muscle cells.

Authors:  E McKilligin; D J Grainger
Journal:  Cell Prolif       Date:  2001-10       Impact factor: 6.831

Review 2.  Tissue engineering in the gut: developments in neuromusculature.

Authors:  Khalil N Bitar; Shreya Raghavan; Elie Zakhem
Journal:  Gastroenterology       Date:  2014-03-27       Impact factor: 22.682

3.  Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function.

Authors:  A W Hahn; T J Resink; T Scott-Burden; J Powell; Y Dohi; F R Bühler
Journal:  Cell Regul       Date:  1990-08

Review 4.  Cell culture systems to study progression and inhibition of intimal proliferations.

Authors:  E Betz
Journal:  Basic Res Cardiol       Date:  1991 Mar-Apr       Impact factor: 17.165

5.  Characteristics of human arterial smooth muscle cell cultures infected with cytomegalovirus.

Authors:  J J Tumilowicz
Journal:  In Vitro Cell Dev Biol       Date:  1990-12

6.  A 90-kd surface antigen from a subpopulation of smooth muscle cells from human atherosclerotic lesions.

Authors:  O J Printseva; M M Peclo; A V Tjurmin; A I Faerman; S M Danilov; V S Repin; V N Smirnov
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

Review 7.  Smooth muscle-protein translocation and tissue function.

Authors:  Thomas J Eddinger
Journal:  Anat Rec (Hoboken)       Date:  2014-09       Impact factor: 2.064

8.  Human smooth muscle cells of the aorta and vena cava: different sensitivity to the inhibition of proliferation by heparin in vitro.

Authors:  D G Thilo-Körner; R H Bödeker
Journal:  Klin Wochenschr       Date:  1985-08-01

9.  Hypoxia selectively induces proliferation in a specific subpopulation of smooth muscle cells in the bovine neonatal pulmonary arterial media.

Authors:  J D Wohrley; M G Frid; E P Moiseeva; E C Orton; J K Belknap; K R Stenmark
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

10.  Human arterial smooth muscle cells in culture: inverse relationship between proliferation and expression of contractile proteins.

Authors:  G Fager; G K Hansson; A M Gown; D M Larson; O Skalli; G Bondjers
Journal:  In Vitro Cell Dev Biol       Date:  1989-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.